These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2013-001640-56 Crossover clinical trial, randomized, double blind, placebo controlled trial. Modulation of cellular mediators and repair endothelial damage in patients with chronic renal disease through inhibition o... not-yet-due
Ongoing 2014-002850-38 EFFICACY AND SAFETY OF EARLY POSTOPERATIVE CHEMOTHERAPY INTRAPERITONEAL (EPIC) WITH PACLITAXEL IN THE RADICAL SURGERY TREATMENT OF OVARIAN PERITONEAL CARCINOMATOSIS not-yet-due
Not reported Terminated 2015-004530-94 Pilot study (Phase II) of Pomalidomide, oral Desamethasone and very low-dose Cyclophosphamide in patients with refractory Multiple Myeloma who have received Lenalidomide and Bortezomib. 2019-05-07 due-trials
Ongoing 2018-003300-39 Clinical trial of efficacy and safety of the combination of reduced duration prophylaxis followed by immuno-guided prophylaxis in lung transplant recipients. not-yet-due
Ongoing 2020-001531-27 Clinical trial of Sarilumab in adults hospitalized with COVID-19 presenting cytokine release syndrome not-yet-due
Ongoing 2020-001541-39 Pilot study of single-dose bevacizumab as a treatment for acute respiratory distress syndrome in patients with COVID-19 not-yet-due
Ongoing 2020-001659-42 Pilot study of antithrombin as prophylaxis of acute respiratory distress syndrome in patients with COVID-19 not-yet-due
Ongoing 2020-001717-20 Prevention and treatment with Calcifediol of Coronavirus COVID-19-induced acute respiratory syndrome (SARS) not-yet-due